Cargando…
Targeting the gut–lung microbiota axis by means of a high-fibre diet and probiotics may have anti-inflammatory effects in COVID-19 infection
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 1 is a 2019 novel coronavirus, which only in the European area has led to more than 300,000 cases with at least 21,000 deaths. This manuscript aims to speculate that the manipulation of the microbial patterns through the use of probiotics...
Autores principales: | Conte, Luana, Toraldo, Domenico Maurizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328354/ https://www.ncbi.nlm.nih.gov/pubmed/32600125 http://dx.doi.org/10.1177/1753466620937170 |
Ejemplares similares
-
Influence of the Lung Microbiota Dysbiosis in Chronic Obstructive Pulmonary Disease Exacerbations: The Controversial Use of Corticosteroid and Antibiotic Treatments and the Role of Eosinophils as a Disease Marker
por: Toraldo, Domenico Maurizio, et al.
Publicado: (2019) -
The Clinical Use of Stem Cell Research in Chronic Obstructive Pulmonary Disease: A Critical Analysis of Current Policies
por: Toraldo, Domenico Maurizio, et al.
Publicado: (2018) -
Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease
por: Li, Lingfeng, et al.
Publicado: (2022) -
Probiotics and the Microbiota-Gut-Brain Axis: Focus on Psychiatry
por: Mörkl, Sabrina, et al.
Publicado: (2020) -
Effective Regulation of Gut Microbiota With Probiotics and Prebiotics May Prevent or Alleviate COVID-19 Through the Gut-Lung Axis
por: Xu, Lei, et al.
Publicado: (2022)